KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
31 hedge funds and large institutions have $35.7M invested in Kalaris Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
5
Increased
9
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
$258K |
2 |
TCM
Tang Capital Management
San Diego,
California
|
$963K |
3 |
Squarepoint
New York
|
$158K |
4 |
Millennium Management
New York
|
$144K |
5 |
XT
XTX Topco
George Town,
Cayman Islands
|
$64.7K |